Skip to main content

Table 3 Drug selection count and fault coverage

From: Application of Max-SAT-based ATPG to optimal cancer therapy design

Drug Vector Count Coverage Drug Vector Count Coverage
000001 3 23% 000111 13 100%
000010 2 15% 001011 6 46%
000100 2 15% 001101 6 46%
001000 1 8% 001110 10 77%
010000 2 15% 010011 7 54%
100000 3 23% 010101 7 54%
000011 5 38% 010110 10 77%
000101 3 23% 011001 6 46%
000110 10 77% 011010 5 38%
001001 4 31% 011100 5 38%
001010 3 23% 100011 8 62%
001100 3 23% 100101 8 62%
010001 5 38% 100110 10 77%
010010 4 31% 101001 7 54%
010100 4 31% 101010 6 46%
011000 3 23% 101100 6 46%
100001 6 46% 110001 6 46%
100010 5 38% 110010 5 38%
100100 5 38% 110100 5 38%
101000 4 31% 111000 4 31%
110000 3 23%    
  1. The drug vectors are grouped according to the number of drugs selected (1, 2, or 3 drugs). The count column notes the number of testable faults rectified by the drug selection, and the coverage shows the count as a percentage of total testable fault rectified. Bold rows indicate drug vectors with highest coverage for the number of drugs used.